Krystexxa

(pegloticase)

Uses, side effects, dosage information & price range

Crealta Pharmaceuticals Ireland Limited

About this medicine

Krystexxa is indicated for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

Colchicine Agepha PharmaComposition: colchicineAgepha Pharma s.r.o.

Price on RequestView Details →

Febuxostat Viatris (previously Febuxostat Mylan)Composition: febuxostatViatris Limited

Price on RequestView Details →

AdenuricComposition: febuxostatMenarini International Operations Luxembourg S.A. (MIOL)

Price on RequestView Details →

Febuxostat KrkaComposition: febuxostatKrka, d.d., Novo mesto

Price on RequestView Details →

DuzalloComposition: allopurinol;lesinuradGrunenthal GmbH

Price on RequestView Details →

Key Information

Salt / Composition

pegloticase